Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue.

Endocrine pathology

Schmid KW, Bankfalvi A, Mucke S, Ofner D, Riehemann K, Schroder S, Stucker A, Totsch M, Dockhorn-Dworniczak B.
PMID: 12114639
Endocr Pathol. 1996;7(2):121-130. doi: 10.1007/BF02739971.

Routinely processed tissues from a series of benign and malignant thyroid lesions were immunohistochemically investigated with antibodies against p53 and mdm-2. p53 was immunolocalized in

Cite
Schmid KW, Bankfalvi A, Mucke S, et al. Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue. Endocr Pathol. 1996;7(2):121-130doi: 10.1007/BF02739971.
Schmid, K. W., Bankfalvi, A., Mucke, S., Ofner, D., Riehemann, K., Schroder, S., Stucker, A., Totsch, M., & Dockhorn-Dworniczak, B. (1996). Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue. Endocrine pathology, 7(2), 121-130. https://doi.org/10.1007/BF02739971
Schmid, Kurt W., et al. "Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue." Endocrine pathology vol. 7,2 (1996): 121-130. doi: https://doi.org/10.1007/BF02739971
Schmid KW, Bankfalvi A, Mucke S, Ofner D, Riehemann K, Schroder S, Stucker A, Totsch M, Dockhorn-Dworniczak B. Possible Relation of p53 and mdm-2 Oncoprotein Expression in Thyroid Carcinoma: A Molecular-Pathological and Immunohistochemical Study on Paraffin-Embedded Tissue. Endocr Pathol. 1996;7(2):121-130. doi: 10.1007/BF02739971. PMID: 12114639.
Copy Download .nbib Format: NLM
Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular C cells using monoclonal antimetallothionein antibody E9.

Endocrine pathology

Schmid KW, Greeff M, Hittmair A, Tötsch M, Öfner D, Dockhorn-Dworniczak B, Böcker W, Jasani B.
PMID: 32370442
Endocr Pathol. 1994 Jun;5(2):114-122. doi: 10.1007/BF02921379.

Metallothioneins (MTs) are a set of ubiquitous low molecular proteins with a high affinity for metal ions, such as zinc, copper, and cadmium. MT overexpression can be induced by these metal ions as well as by other endogenous and...

Cite
Schmid KW, Greeff M, Hittmair A, et al. Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular C cells using monoclonal antimetallothionein antibody E9. Endocr Pathol. 1994;5(2):114-122doi: 10.1007/BF02921379.
Schmid, K. W., Greeff, M., Hittmair, A., Tötsch, M., Öfner, D., Dockhorn-Dworniczak, B., Böcker, W., & Jasani, B. (1994). Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular C cells using monoclonal antimetallothionein antibody E9. Endocrine pathology, 5(2), 114-122. https://doi.org/10.1007/BF02921379
Schmid, Kurt W, et al. "Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular C cells using monoclonal antimetallothionein antibody E9." Endocrine pathology vol. 5,2 (1994): 114-122. doi: https://doi.org/10.1007/BF02921379
Schmid KW, Greeff M, Hittmair A, Tötsch M, Öfner D, Dockhorn-Dworniczak B, Böcker W, Jasani B. Metallothionein expression in normal, hyperplastic, and neoplastic thyroid follicular and parafollicular C cells using monoclonal antimetallothionein antibody E9. Endocr Pathol. 1994 Jun;5(2):114-122. doi: 10.1007/BF02921379. PMID: 32370442.
Copy Download .nbib Format: NLM
Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in primary non-small-cell carcinomas of the lung.

Endocrine pathology

Tötsch M, Kunk B, Dockhorn-Dworniczak B, Öfner D, Fischer-Colbrie R, Mikuz G, Böcker W, Schmid KW.
PMID: 32138452
Endocr Pathol. 1994 Dec;5(4):212-217. doi: 10.1007/BF02921488.

Fifty-three primary non-small-cell lung carcinomas (NSCLC) were immunohistochemically investigated with antibodies against chromogranin A, chromogranin B, and ecretoneurin. All 3 peptides were focally immunolocalized in 3 of 25 adenocarcinomas and in 2 of 6 large-cell anaplastic carcinomas in more...

Cite
Tötsch M, Kunk B, Dockhorn-Dworniczak B, et al. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in primary non-small-cell carcinomas of the lung. Endocr Pathol. 1994;5(4):212-217doi: 10.1007/BF02921488.
Tötsch, M., Kunk, B., Dockhorn-Dworniczak, B., Öfner, D., Fischer-Colbrie, R., Mikuz, G., Böcker, W., & Schmid, K. W. (1994). Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in primary non-small-cell carcinomas of the lung. Endocrine pathology, 5(4), 212-217. https://doi.org/10.1007/BF02921488
Tötsch, Martin, et al. "Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in primary non-small-cell carcinomas of the lung." Endocrine pathology vol. 5,4 (1994): 212-217. doi: https://doi.org/10.1007/BF02921488
Tötsch M, Kunk B, Dockhorn-Dworniczak B, Öfner D, Fischer-Colbrie R, Mikuz G, Böcker W, Schmid KW. Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in primary non-small-cell carcinomas of the lung. Endocr Pathol. 1994 Dec;5(4):212-217. doi: 10.1007/BF02921488. PMID: 32138452.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries